EACVI President

European Association of Cardiovascular Imaging President X account. Posts by @VictoriaDe32503 and her team. #EACVI #CVImaging #echofirst #whyCMR #yesCCT

[EACVI President @EACVIPresident]

11/
Until then, I wish you all some well-deserved downtime, a joyful festive season, and happy holidays.
Thank you for being part of the #EACVI family.
@VDelgadoGarcia

[EACVI President @EACVIPresident]

Make the most of ESC Congress 2026 with the selection of EACVI Recommended Sessions.

Discover the key imaging-focused sessions handpicked by EACVI experts and stay up to date with the latest advances across the cardiovascular imaging field.

Browse the programme and add your must-attend sessions to your Congress agenda today.

https://t.co/S6mkxY9kVP

@rafavidalperez @YBououdina @MSBBrandao @ydaryani @Elizabeth_antos @pfelissamburu @CharlesFauvel @alexsfelixecho @galzeranod @andgiannopmd @hrt01a @WilliamKokFaiK1 @M_Marwan_ @drahmedmohsen85 @aniela_petrescu @benayozbay @slumberbell @senguptasp @ElizabetaK10533 @samsrivastava77 @MihaiTrofenciuc @C_VanDeHeyning @drozgeozden @Giulia_Vinco @VazyurVasquez @Sarah_Moharem @denisamuraru @s_e_petersen @VictoriaDe32503

[rafavidalperez @rafavidalperez]

#ESCCongress 2026 @escardio is getting near don´t miss anything https://t.co/cLMGdYUs85 Transforming Cardiology Together ... Remember that the spotlight is #ArtificialIntelligence #EHJDigital

[EACVI President @EACVIPresident]

🚨 New research in cardiac amyloidosis

A new study in @EHJIMPEiC highlights the potential of CMR native T1 mapping and extracellular volume (ECV) to help diagnose cardiac amyloidosis in patients with heart failure.

Among 112 patients:
🔹 34% were diagnosed with cardiac amyloidosis
🔹 Native T1 <1,303 ms → no amyloidosis identified
🔹 ECV <30% → no amyloidosis identified
🔹 ECV 40–49% → 85% had amyloidosis
🔹 ECV ≥50% → 100% had amyloidosis
🔹 ECV showed excellent diagnostic performance (AUC 0.904)

Importantly, the proposed CMR pathway could potentially avoid gadolinium contrast in one-third of patients and definitively confirm or exclude cardiac amyloidosis in around half.

A promising demonstration of how quantitative CMR may streamline the diagnostic pathway for cardiac amyloidosis—although these thresholds need validation before being applied universally.

@rafavidalperez @YBououdina @MSBBrandao @ydaryani @Elizabeth_antos @pfelissamburu @CharlesFauvel @alexsfelixecho @galzeranod @andgiannopmd @hrt01a @WilliamKokFaiK1 @M_Marwan_ @drahmedmohsen85 @aniela_petrescu @benayozbay @slumberbell @senguptasp @ElizabetaK10533 @samsrivastava77 @MihaiTrofenciuc @C_VanDeHeyning @drozgeozden @Giulia_Vinco @VazyurVasquez

https://t.co/bPqvHEB1Hj

#CardiacAmyloidosis #ATTR #Cardiology #CMR #CardiacMRI #HeartFailure #MedicalResearch

[EACVI President @EACVIPresident]

Advance your expertise in HCM imaging with the #EACVI HCM Masterclass 24-25 September in Lisbon, Portugal.
This intensive 1.5-day course is designed for cardiologists establishing an #HCM clinic and those wishing to specialise in hypertrophic cardiomyopathy.
Learn from international experts through case-based discussions and multimodality imaging sessions.

👉 Discover more and register:

https://t.co/TVBoKh63n2

#CVImaging #echofirst #CCT #whyCMR

@rafavidalperez @YBououdina @MSBBrandao @ydaryani @Elizabeth_antos @pfelissamburu @CharlesFauvel @alexsfelixecho @galzeranod @andgiannopmd @hrt01a @WilliamKokFaiK1 @M_Marwan_ @drahmedmohsen85 @aniela_petrescu @benayozbay @slumberbell @senguptasp @ElizabetaK10533 @samsrivastava77 @MihaiTrofenciuc @C_VanDeHeyning @drozgeozden @Giulia_Vinco @VazyurVasquez @Sarah_Moharem @denisamuraru @s_e_petersen @VictoriaDe32503

[Sarah Moharem Elgamal, MBBCh, MSc, PhD👩🏻‍⚕️🫀 @Sarah_Moharem]

📢 Cardiac CT is much more than coronary imaging.

Delighted to be a co-author of the new #EACVI / @escardio Council of Cardiology Practice Clinical Consensus Statement on the implementation of #CCT in everyday practice, published in the @ehj_ed @ESC_Journals .

We focus on four practical questions:

1️⃣ What can cardiac CT detect and assess?
2️⃣ How can CT contribute to risk stratification?
3️⃣ What information should be included in the referral?
4️⃣ What should clinicians look for in the CT report?

From coronary and valvular disease to cardiomyopathies, cardiac masses, great vessels and congenital heart disease, the document highlights how #CCT can provide clinically actionable anatomical, functional and prognostic information.

@gpontone1 @StefanoNistri @drkharabish @JRodriPalomares @denisamuraru @s_e_petersen @VictoriaDe32503 @EACVIPresident

https://t.co/rdMfRBzmxr

[EACVI President @EACVIPresident]

It was a pleasure to open the @thecsanz #CSANZ26 Imaging Council Symposium on Multimodality Imaging: New Horizons.

My sincere thanks to symposium chairs Dr @rebeccakozor and Dr Sandhir Prasad for the kind invitation and excellent organization.

Delighted to share insights into the evolving role of high-rate #echocardiography and discuss how emerging imaging technologies are shaping the future of cardiovascular care.

Thank you to everyone for the engaging discussions and warm welcome. Looking forward to continued collaboration between #EACVI and the #CSANZ imaging community.

@NAjmoneMarsan @gpontone1 @carpenter_jp @LunaGargani @anatimoteo46040 @Matte_Cameli @DrGEMandoli @Ph_Bertrand @EchoSoliman @andgiannopmd @PezelT @rmanka_ @AnnaBaritussio @Sarah_Moharem @denisamuraru @s_e_petersen @VictoriaDe32503

[EHJ-IMP Editor-in-Chief @EHJIMPEiC]

🫀🎥 When anatomy doesn’t match ischaemia… think beyond coronary disease.
A fascinating case shows how advanced 4D echocardiography (TrueVue Glass) helped uncover the real diagnosis 👇
✨ Clinical puzzle:
🩺 Post-PCI patient
⚠️ New left ventricular aneurysm (VA)
❗ Location didn’t match coronary territory → red flag
🔍 Multimodality insight:
🎥 TrueVue Glass (4D echo) → detailed visualization of aneurysm morphology
🔥 FDG-PET → focal metabolic activity
🧲 CMR → LGE in aneurysmal region
📊 As shown in Panel A (page 1):
👉 Imaging mismatch triggered deeper investigation
🔥 Key innovation:
👉 TrueVue Glass provides:
👁️ Superior endocardial border definition
🎯 Real-time 4D visualization (like LV angiography!)
⚡ Better spatial understanding without contrast
💡 Final diagnosis:
👉 Cardiac sarcoidosis
🚨 Clinical message:
👉 Not every aneurysm is ischaemic
👉 Multimodality imaging = diagnostic clarity
🎯 Big take-home:
From “unexpected finding”
➡️ to
“integrated imaging → precise diagnosis”
📄 Read the full paper:
👉
🔗 DOI: 10.1093/ehjimp/qyag011
#Cardiology #Echocardiography #CMR #CardiacPET #Sarcoidosis #MultimodalityImaging #CardioTwitter #Imaging #MedTech #PrecisionMedicine 🧠💓

[Hatem Soliman Aboumarie, FRCP, FEACVI, FASE, FHEA @EchoSoliman]

Day 2 #EchoNagpur with lots and lots of educational cases #echofirst @EACVIPresident @escardio

[EHJ-IMP Editor-in-Chief @EHJIMPEiC]

🎥🫀 What if cardiac CT could show valves in motion… like real life?
A new study introduces the first use of 4D cinematic rendering (CR) in cardiac imaging 👇
✨ What’s new:
🧠 3D cinematic rendering + time = 4D visualization
🎬 Full cardiac cycle in motion
👁️ Enhanced depth perception & realism
📊 As shown in the videos and images (pages 1–2):
👉 Dynamic visualization of:
🔁 Valve prolapse (tricuspid & mitral)
📍 Annular disjunctions
⚠️ Malcoaptation
🌊 Even regurgitant jets (not visible in standard CT!)
🔥 Game-changing advantage:
👉 Not just anatomy… but dynamic valve behaviour
💡 Additional insight:
📍 Clear relationship between tricuspid annulus & RCA
→ crucial for procedural planning
🚨 Clinical message:
Standard CT = static anatomy
4D CR = real-time functional anatomy
🎯 Big take-home:
From “seeing structures”
➡️ to
“watching the heart move in 3D space and time”
📄 Read the full paper:
👉
🔗 DOI: 10.1093/ehjimp/qyaf165
#Cardiology #CardiacCT #4Dimaging #CinematicRendering #ValvularHeartDisease #ImagingInnovation #CardioTwitter #MedTech #DigitalHealth 🧠💓

[EACVI President @EACVIPresident]

🏆 The Excellence in Education Awards celebrate outstanding educators in cardiovascular imaging.
Are you making a difference in education? Apply for the EACVI Award for Excellence in Education.
Know someone who deserves this recognition? Nominate them!

📅 Applications are open until 30 September 2026.

🔗 Learn more and apply: https://t.co/HviTkxpZOz…

@anatimoteo46040 @ElenaGalli10

@rafavidalperez @YBououdina @MSBBrandao @ydaryani @Elizabeth_antos @pfelissamburu @CharlesFauvel @alexsfelixecho @galzeranod @andgiannopmd @hrt01a @drahmedmohsen85 @aniela_petrescu @benayozbay @slumberbell @samsrivastava77 @C_VanDeHeyning @drozgeozden @Giulia_Vinco @VazyurVasquez @Sarah_Moharem @denisamuraru @s_e_petersen @VictoriaDe32503

[European Society of Cardiology @escardio]

Recognition. Community. Leadership.

As Prof. Mamotabo Rossy Matshela reminds us, "Don't underestimate your potential or your credentials."

Becoming a Fellow of the ESC (FESC) is an opportunity to gain international recognition, connect with a global network of cardiovascular professionals, and contribute to shaping the future of cardiology.

Apply by 30 September https://t.co/DcER2JY5oo

[EACVI President @EACVIPresident]

In the latest episode of Advances in Cardiovascular Imaging, Dr @slumberbell is joined by Professor @gpontone1 to discuss the paper, “Redefining the Risk of Major Arrhythmic Events in Non-Ischaemic Cardiomyopathy: Insights from the DERIVATE-NICM Study.”

The conversation explores how cardiac magnetic resonance (CMR), late gadolinium enhancement (LGE) pattern distribution, and the DERIVATE Risk Score 2.0 could improve arrhythmic risk stratification and guide ICD selection in patients with non-ischaemic cardiomyopathy. The study found that incorporating the presence and location of midwall LGE significantly improved prediction of major arrhythmic events compared with traditional LVEF-based assessment alone.

🎧https://t.co/Y5frYdsgRR

Read the paper here: https://t.co/iBaNGwjnlD

@rafavidalperez @YBououdina @MSBBrandao @ydaryani @Elizabeth_antos @pfelissamburu @CharlesFauvel @alexsfelixecho @galzeranod @andgiannopmd @hrt01a @WilliamKokFaiK1 @M_Marwan_ @drahmedmohsen85 @aniela_petrescu @benayozbay @senguptasp @ElizabetaK10533 @samsrivastava77 @MihaiTrofenciuc @C_VanDeHeyning @drozgeozden @Giulia_Vinco @VazyurVasquez @LunaGargani @carpenter_jp @Sarah_Moharem @s_e_petersen @denisamuraru @VictoriaDe32503

#Cardiology #CardiacImaging #CMR #CardiacMRI #HeartFailure #Electrophysiology #ICD #SuddenCardiacDeath #Cardiomyopathy #MedEd

[Jan Verwerft @VerwerftJan]

New in @ESC_Journals - Cardiovascular Imaging

Which patients with aortic stenosis (#AS) benefit most from exercise hemodynamics?
🧵1/8
We propose a simple stepwise approach:
📍Cardiac damage staging (@PhilGenereuxMD )
📍Exercise hemodynamics in patients with early cardiac damage

[EACVI President @EACVIPresident]

🚨 Registration for #EACVI l2026 is OPEN! 🇮🇹

Join the global cardiovascular imaging community in Milan, Italy, from 3–5 December 2026.

This year’s congress brings together the excellence of #EuroEcho, #EuroCMR, and #ICNCCT under one roof, offering:
🔹 Dedicated single-modality tracks
🔹 An optional multimodality track to broaden your expertise
🔹 Expert-led case discussions and live demonstrations
🔹 Opportunities to connect with leading imaging professionals from around the world

💡 Register by 30 September to secure the best available rates, with additional discounts for #EACVI Members, nurses, allied professionals, and trainees.

Don’t miss this opportunity to advance your knowledge, strengthen your clinical practice, and be part of one of the world’s premier #CVImaging meetings!

@denisamuraru @s_e_petersen @NAjmoneMarsan @gpontone1 @EchoSoliman @RFontesCarvalho @rmanka_ @Matte_Cameli @DrGEMandoli @anatimoteo46040 @AnnaBaritussio @andgiannopmd @PezelT @Ph_Bertrand @Sarah_Moharem @VictoriaDe32503

#EACVI2026 #CardiovascularImaging #Echocardiography #CardiacMRI #CardiacCT #NuclearCardiology #Cardiology #MedicalEducation #ESC

[European Society of Cardiology @escardio]

One congress, every perspective – deepen your expertise while embracing the bigger picture at #EACVI26 🩷

Join us in Milan from 3–5 December, where EuroEcho, EuroCMR and ICNC-CT come together to deliver world-class education across cardiovascular imaging.

Register today and benefit from the best rates 👉 https://t.co/At2SxK9wVF

#EACVI @EACVIPresident

[EACVI President @EACVIPresident]

🚨 Have your say on cardiac amyloidosis imaging practice across Europe!

The EACVI Scientific Initiatives Committee (SIC) is conducting a survey to better understand current practices in the suspicion and diagnosis of cardiac amyloidosis using multimodality imaging.

📝 Your input will help:
• Identify gaps in access, training, and clinical workflows
• Inform future EACVI guidance
• Shape targeted educational and implementation initiatives to support high-quality, imaging-led care

⏱️ The survey takes less than 8 minutes to complete and can be accessed easily on your smartphone, tablet, or laptop.

👉 Access the survey:https://t.co/3paTl1TrrS

Thank you for contributing to this important European initiative and helping advance the care of patients with cardiac amyloidosis.

#EACVI #CardiacAmyloidosis #CardiacImaging #Echocardiography #CMR #NuclearCardiology #MultimodalityImaging #Cardiology #MedicalEducation #ESC

@rafavidalperez @YBououdina @MSBBrandao @ydaryani @Elizabeth_antos @pfelissamburu @CharlesFauvel @alexsfelixecho @galzeranod @andgiannopmd @hrt01a @WilliamKokFaiK1 @M_Marwan_ @drahmedmohsen85 @aniela_petrescu @benayozbay @slumberbell @senguptasp @ElizabetaK10533 @samsrivastava77 @MihaiTrofenciuc @C_VanDeHeyning @drozgeozden @Giulia_Vinco @VazyurVasquez @Sarah_Moharem @s_e_petersen @denisamuraru @VictoriaDe32503

[Associate Prof William KF Kong 江国辉副教授 @WilliamKokFaiK1]

I am glad to share that Prof Delgado, A/P Wong myself are conducting The Hands-on Echocardiography Workshop takes place in Brunei Darussalam as part of AFCC 2026. this workshop covers advanced techniques like AI integration, 3D echocardiography, and valve evaluations. Do join us

[EACVI President @EACVIPresident]

🚨 New Research | Acute Decompensated Heart Failure

Can combining venous congestion assessment (VExUS) with lung ultrasound (LUS) improve risk stratification in acute decompensated heart failure?

A newly published study in the @EHJIMPEiC evaluated 104 patients with acute decompensated heart failure and found that early serial changes in VExUS and lung ultrasound, integrated into the novel ΔVExPLUs score, were strongly associated with clinical outcomes. Patients with less improvement in congestion had a significantly higher risk of adverse events.

💡 Key takeaway: Combining systemic venous congestion and pulmonary congestion into a single bedside ultrasound assessment may provide a more comprehensive and clinically meaningful way to monitor decongestion and identify high-risk patients early during hospitalization.

This study highlights the growing role of multiorgan point-of-care ultrasound in guiding heart failure management and improving prognostic assessment.

Read the article here:

https://t.co/re3TSKKJ8N

@rafavidalperez @YBououdina @MSBBrandao @ydaryani @Elizabeth_antos @pfelissamburu @CharlesFauvel @alexsfelixecho @galzeranod @andgiannopmd @hrt01a @WilliamKokFaiK1 @M_Marwan_ @drahmedmohsen85 @aniela_petrescu @benayozbay @slumberbell @senguptasp @ElizabetaK10533 @samsrivastava77 @MihaiTrofenciuc @C_VanDeHeyning @drozgeozden @Giulia_Vinco @VazyurVasquez

#HeartFailure #POCUS #Ultrasound #Cardiology #VExUS #LungUltrasound #Echocardiography #MedicalEducation #FOAMed #CardioTwitter

[Erik Rafflenbeul @KardiologieHH]

🫀 What happens when an #EscapeRoom meets the #HeartTeam? 🧩

No lectures. Just real-time decisions, teamwork &amp; guideline-based medicine.

Excited to co-lead the #ValvularHeartDisease station with Elena Romero-Dorta for #EAPCI &amp; #EACVI at #ESCHeartTeamChallenge #ESCCongress 2026

[EHJ-IMP Editor-in-Chief @EHJIMPEiC]

🧬🫀 We image the scar… but do we really understand it?
A new review explores how molecular contrast agents are redefining imaging after myocardial infarction 👇
✨ Key insights:
❤️ Post-MI remodelling drives heart failure & mortality
📊 Conventional imaging (CMR, PET) shows:
👉 infarct size
👉 function
❌ but NOT the underlying biology
🔬 Molecular imaging targets the real drivers:
👉 inflammation
👉 fibroblast activation
👉 scar formation
💡 As shown in the graphical abstract (page 2):
👉 Conventional imaging = what we see
👉 Molecular imaging = what is happening
🔥 Game changer:
Detect disease earlier (before structural changes)
Identify stage of remodelling (inflammatory → proliferative → fibrotic)
Guide targeted therapies (e.g. anti-inflammatory, anti-fibrotic)
🚀 Examples of next-gen tracers:
🧲 SPIONs → macrophage activity (MRI)
🔥 FDG / DOTATATE → inflammation (PET)
🧵 FAPI → fibroblast activation
🧱 Collagen/elastin tracers → scar maturation
🎯 Big take-home:
From “how big is the infarct?”
➡️ to
“what biology is driving the remodelling?”
📄 Read the full paper:
👉
🔗 DOI: 10.1093/ehjimp/qyag019
#Cardiology #CMR #CardiacPET #MolecularImaging #HeartFailure #PrecisionMedicine #CardioTwitter #Research #MedTech #PostMI 🧠💓

[Shehab Anwer, MD @ShehabAnwer]

🎙️Explore how intrinsic myocardial muscle drives sys function reduction in #AorticStenosis patients in the latest #IMPactPodcast with Dr. Uusitalo with #EHJIMP hosts @EZancanaroMD & @AnnaKateBarton 🫀 https://t.co/ThdWz4ReQo

@ESC_Journals @EHJIMPEiC @alessia_gimelli @EACVIPresident